Bioventus annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Bioventus Depreciation & Amortization Growth & History (BVS)
Bioventus's depreciation and amortization was $47.0M for fiscal 2025.
View full Bioventus company overviewBioventus annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $47.0M | −$2.5M | −5.13% |
| 2024 | 2024-12-31 | $49.6M | −$7.8M | −13.61% |
| 2023 | 2023-12-31 | $57.4M | $2.0M | +3.55% |
| 2022 | 2022-12-31 | $55.4M | $20.5M | +58.85% |
| 2021 | 2021-12-31 | $34.9M | $6.2M | +21.76% |
| 2020 | 2020-12-31 | $28.6M | −$1.7M | −5.52% |
| 2019 | 2019-12-31 | $30.3M | — | — |
Bioventus quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-27 | $1.0M | −$398,000 | −27.66% |
| Q1 2026 | 2026-03-28 | $11.2M | −$660,000 | −5.56% |
| Q4 2025 | 2025-12-31 | $11.7M | — | — |
| Q3 2025 | 2025-09-27 | $1.4M | −$667,000 | −32.30% |
| Q2 2025 | 2025-06-28 | $1.4M | −$625,000 | −30.28% |
| Q1 2025 | 2025-03-29 | $11.9M | $80,000 | +0.68% |
| Q3 2024 | 2024-09-28 | $2.1M | −$252,000 | −10.88% |
| Q2 2024 | 2024-06-29 | $2.1M | −$230,000 | −10.03% |
| Q1 2024 | 2024-03-30 | $11.8M | −$4.7M | −28.46% |
| Q3 2023 | 2023-09-30 | $2.3M | $62,000 | +2.75% |
| Q2 2023 | 2023-07-01 | $2.3M | −$402,000 | −14.91% |
| Q1 2023 | 2023-04-01 | $16.5M | $4.0M | +32.01% |
| Q3 2022 | 2022-10-01 | $2.3M | $377,000 | +20.07% |
| Q2 2022 | 2022-07-02 | $2.7M | $844,000 | +45.57% |
| Q1 2022 | 2022-04-02 | $12.5M | $5.3M | +73.71% |
| Q3 2021 | 2021-10-02 | $1.9M | $211,000 | +12.66% |
| Q2 2021 | 2021-07-03 | $1.9M | $39,000 | +2.15% |
| Q1 2021 | 2021-04-03 | $7.2M | −$81,000 | −1.11% |
| Q3 2020 | 2020-09-26 | $1.7M | — | — |
| Q2 2020 | 2020-06-27 | $1.8M | — | — |
| Q1 2020 | 2020-03-28 | $7.3M | — | — |
Bioventus depreciation and amortization trends
Over the last five fiscal years, Bioventus's depreciation and amortization increased from $28.6M to $47.0M, a change of $18.4M. The latest reported quarter, Q2 2026, shows $1.0M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioventus source filings ↗